Amol Akhade/X
Oct 29, 2025, 07:13
Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
Amol Akhade, Senior Medical and Hemato-Oncologist at Fortis Hospital Mumbai and Founder of Suyog Cancer Clinics, shared a post on X:
“Happy To Share Our Paper published In Lancet Oncology. It is joint venture between myself and Manju Sengar and Dr Roni Levin and Daniel Goldstein from Israel .
We closely looked at Subcut IO drugs approvals and discuss that even though sub cut formulations are more convenient they may actually prolong patents and may delay entry of Biosimilar IO drugs.
Wolf in Sheep clothing. Classic essay in Pharmaco Economics”
Title: Subcutaneous immunotherapy—a wolf in sheep’s clothing?
Authors: Roni Levin, Amol Akhade, Manju Sengar, Daniel A Goldstein
Read full paper here
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS